Koya Ariyoshi
- Professor, Department of Clinical Medicine, Institute of Tropical Medicine
- Infectious Diseases, Tropical Medicine
- HIV/AIDS, Tropical Infectious Diseasease, Respiratory Infectious Diseases
You must study harder and harder if you truly want to contribute yourself to the health of people living in already resource limited countries.
▼Course List
Management and Control of Tropical Infectious Diseases
▼Recommended books
Peter Piot. NO TIME TO LOSE a life in pursuit of deadly viruses. （New York/London, W. W. Norton & Company, 2012）
▼Homepage
http://www.tm.nagasaki-u.ac.jp/internal/nekkennaika.htm
personal history
Diploma of Tropical Medicine and Hygiene, London (1988), Master of Science in Clinical Tropical Medicine, LSHTM (1989), St. Mary's hospital, London (-1992), UK MRC laboratories, The Gambia, West Africa (-1998), National Institute of Infectious Diseases, Tokyo / JICA expert for Thai NIH (-2005)
works/thesis
1. Schmidt WP, Suzuki M, Dinh Thiem V, White RG, Tsuzuki A, Yoshida LM, Yanai H, Haque U, Huu Tho L, Anh DD, Ariyoshi K. Population density, water supply, and the risk of dengue Fever in Vietnam: cohort study and spatial analysis. PLoS Med. 2011 Aug;8(8):e1001082. Epub 2011 Aug 30.
2. Suzuki M, Thiem VD, Yanai H, Matsubayashi T, Yoshida LM, Tho LH, Minh TT, Anh DD, Kilgore P, Ariyoshi K. Environmental tobacco smoking exposure is associated with an increased risk of hospitalized pneumonia among children under 5 years old in Vietnam. Thorax. 2009 Jun;64(6):484-9.
3. Pathipvanich P, Ariyoshi K, Rojanawiwat A, Wongchoosie S, Yingseree P, Yoshiike K, Warachit P, Sawanpanyalert P. Survival benefit from non-highly active antiretroviral therapy in a resource-constrained setting. J Acquir Immune Defic Syndr. 2003 Feb 1; 32(2): 157-60.
4. Ariyoshi K, Cham F, Berry N, Jaffar S, Sabally S, Corrah T, Whittle H. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS 1995; 9: 555-559.
5. Ariyoshi K, Harwood E, Chiengsong-Popov R, Weber J. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies? Lancet 1992; 340: 1257-1258.